Dermata Therapeutics (DRMA) vs Pulmatrix (PULM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Pulmatrix is the larger company by market cap ($5.3 million vs $5.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | DRMA | PULM |
|---|---|---|
| Share price | $1.06 | $1.46 |
| Market cap | $5.25M | $5.31M |
| 1-day change | -5.36% | -2.35% |
| EPS (TTM) | $-4.39 | $-1.10 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.84 | $5.24 |
| 52-week low | $0.951 | $1.16 |
| Distance from 52-week high | -78.10% | -72.21% |
| Average volume | 708.18K | 24.75K |
| Shares outstanding | 4.96M | 3.65M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
DRMA vs PULM FAQ
Which is bigger, Dermata Therapeutics or Pulmatrix?
Pulmatrix (PULM) is larger, with a market capitalization of $5.31M compared with $5.25M for Dermata Therapeutics (DRMA).
Are Dermata Therapeutics and Pulmatrix in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.